Last reviewed · How we verify
Midazolam and Ketamine
At a glance
| Generic name | Midazolam and Ketamine |
|---|---|
| Also known as | Midazolam, Dormire ® (Cristalia Lab, Sao Paulo, Brazil), Ketamine, Ketamin ® (Cristalia Lab, Sao Paulo, Brazil) |
| Sponsor | Universidade Federal de Goias |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery (PHASE1)
- The Impact of a Shared Decision-Making Intervention on Intraoperative Patient Experience During Elective Cesarean Delivery Under Spinal Anesthesia (NA)
- A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder (PHASE3)
- Ketamine, SGB and Combination Treatment for TBI (PHASE2)
- Prospective IR-led Sedation Feasibility (PHASE1, PHASE2)
- Ketamine for Treatment-Resistant Bipolar Disorder (PHASE2)
- Comparative Assessment of Oral Premedication Regimens in Pediatric Ambulatory Surgery (NA)
- Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |